Home / Inspections / 894095

FDA Inspection 894095 — Octapharma AB

Octapharma AB — FEI 3005559915

The FDA completed an inspection of Octapharma AB on April 28, 2014 in Stockholm. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 28, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Stockholm (Sweden)

Facility

Other inspections at this facility

  • 1218250 (VAI Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1070173 (VAI Fri Sep 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 783783 (VAI Thu Jan 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 710676 (OAI Thu Jan 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 580664 (VAI Thu Jan 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources